期刊文献+

烟酸凝胶骨架缓释片的稳定性考察

Study On Stability of Nicotinic Acid Gel Matrix Sustained Release Tablets
下载PDF
导出
摘要 目的:考察烟酸凝胶骨架缓释片贮存期间稳定性。方法:采用加速试验和长期试验方法,考察外观性状、含量和释放度。结果:密封包装条件下,36个月内外观性状、含量和释放度检查结果没有显著性变化。结论:该制剂密封条件下贮存,有效期可以定为2年。 Objective: To investigate the stability of gel matrix sustained release tablets of nicotinic acid in storied terms. Method: The characters, content and release rate were studied by the accelerated and long-term tests. Result: Under the tight packing condition, no obvious changes were observed for the characters, contents and release rate of the samples within 36 months. Conclusion: Storied in tight container, the recommended validity life of tablets is 2 years.
出处 《中国药师》 CAS 2008年第11期1329-1331,共3页 China Pharmacist
关键词 烟酸 缓释片 稳定性 Nicotinic acid Sustained release tablets Stability
  • 相关文献

参考文献4

二级参考文献24

  • 1董志超,蒋雪涛.羟丙基甲基纤维素在凝胶骨架中的含量与水溶性药物释放机制的关系[J].药学学报,1996,31(1):43-47. 被引量:31
  • 2平其能 郑梁元.药用聚合物的理论和实践[M].北京:中国医药科技出版社,1994.410-412.
  • 3PIEPER JA. Overview of niacin formulations: differences in pharmacokinetics, efficacy, and safety [J]. Am J Health Syst Pharos, 2003, 60 (13 Suppl 2): S9-S14.
  • 4SCANU AM. The role of lipoprotein (a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events[J]. Curr Cardiol Rep, 2001, 3(5): 385-390.
  • 5KAMANNA VS, KASHYAP ML. Mechanism of action of niacin on lipoprotein metabolism[J]. Curr Atheroscler Rep, 2000, 2(1): 36-46.
  • 6ROBINSON AW, SLOAN HL, ARNOLD G. Use of niacin in the prevention and management of hyperlipidemia[J]. Prog Cardiovasc Nurs, 2001, 16 (1): 14-20.
  • 7GANJI SH, KAMANNA VS, KASHYAP ML. Niacin and cholesterol: role in cardiovascular disease[J] . J Nutr Biochem, 2003,14 (6): 298-305.
  • 8GUPTA EK, ITO MK. Lovastatin and extended-release niacin combination product: the first drug combination for the management of hyperlipidemia [J]. Heart Dis, 2002, 4 (2): 124-137.
  • 9KNOPP RH, ALAGONA P, DAVIDSON M, et al. Equivalent efficacy of a time-release form of niacin (Niaspan) given oncea-night versus plain niacin in the management of hyperlipidemia[J]. Metabolism, 1998, 47 (9): 1097-1104.
  • 10PIEPER JA. Understanding niacin formulations [J]. Am J Manag Care, 2002, 8 (12 Suppl): S308-S314.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部